BCAX Competitors & Alternatives
Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry
Biotechnology
BCAX
Main Stock$17.63
Tradestie Score
50
Market Cap
$906.29M
Analyst Upside
+101.4%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NUVB
Nuvation Bio Inc.
|
$5.14
|
$1.27B | - | 55 | Compare |
|
YDES
YD Bio Limited Ordinary Shares
|
$8.11
|
$1.26B | - | 36 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$8.54
|
$1.18B | - | 35 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$46.97
|
$1.17B | - | 66 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.50
|
$1.15B | 4.9 | 44 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.91
|
$1.14B | - | 61 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$12.21
|
$1.14B | - | 53 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$26.43
|
$1.13B | - | 37 | Compare |
More BCAX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry